期刊文献+

阿司匹林联合氯吡格雷对冠心病心绞痛患者血清hs-CRP、TNF-α及IL-6水平的影响研究 被引量:35

Effect of aspirin combined with clopidogrel on serum levels of hs-CRP,TNF-alpha and IL-6 in patients with coronary heart disease and angina pectoris
下载PDF
导出
摘要 目的研究阿司匹林联合氯吡格雷对冠心病心绞痛患者血清血清高敏C-反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)及白细胞介素-6(IL-6)水平的影响,为临床诊治提供参考。方法选取我院于2016年11月至2017年11月收治的80例冠心病心绞痛患者患者,按照随机数表法平均分成两组。其中对照组采用阿司匹林治疗;观察组患者在对照组基础上联合氯吡格雷治疗,两组患者均进行30 d的治疗。对比两组患者治疗后临床疗效,血清脂质水平,hs-CRP、TNF-α及IL-6水平。结果治疗后,对照组患者总有效率77.5%,观察组总有效率85.0%,差异有统计学意义(P<0.05)。治疗后,两组患者TC、TG及LDL-C等血脂水平均较治疗前明显改善,且观察组优于对照组,差异均有统计学意义(P<0.05);且治疗后,两组患者血清hs-CRP、TNF-α及IL-6均较治疗前明显改善,且观察组优于对照组,差异均有统计学意义(P<0.05)。结论阿司匹林联合氯吡格雷治疗冠心病心绞痛,可显著提高患者临床疗效,改善患者TC、TG及LDL-C等血清脂质指标及hs-CRP、TNF-α及IL-6水平,值得在临床上推广。 Objective To study the protein reaction of aspirin combined with clopidogrel on coronary heart disease angina pectoris serum serum high-sensitivity C-(high-sensitivity C-reactive protein,hs-CRP),tumor necrosis factor alpha(tumor necrosis factor-TNF-alpha,alpha)and interleukin-6(interleukin-6,IL-6)level,provide reference for clinical diagnosis and treatment. Methods In our hospital from November 2016 to November 2017 treated 80 cases of patients with angina pectoris were randomly divided into two groups. The control group was treated with aspirin;the observation group was treated with clopidogrel on the basis of the control group,and the two groups were treated with 30 D. The clinical efficacy,serum lipid levels,hs-CRP,TNF-alpha and IL-6 levels were compared between the two groups after treatment. Results after treatment,the total effective rate of the control group was 77.5%,and the total effective rate of the observation group was85%,the difference was statistically significant(P〈0.05). After treatment,blood lipid levels of two groups were TC,TG and LDL-C were significantly improved after treatment,and the observation group than the control group,the differences were statistically significant(P〈0.05);and after treatment,two groups of patients with serum hs-CRP,TNF-alpha and IL-6 were significantly improved after treatment,and the observation group than the control group. The differences were statistically significant(P〈0.05). Conclusion Aspirin combined with clopidogrel in the treatment of coronary heart disease angina pectoris can significantly improve the clinical efficacy of patients,improve the serum lipid indexes such as TC,TG and LDL-C,and the levels of hs-CRP,TNF-alpha and IL-6 in patients with coronary heart disease,which is worthy of clinical promotion.
作者 尹叶全 YIN Ye-quan.(Medical Outpatient Pharmacy, Group of Fifth Hospital, Pharma-ceutical Corporation East Hubei, Huangshi, Hubei Province 435005, Chin)
出处 《解剖学研究》 CAS 2018年第3期178-181,共4页 Anatomy Research
关键词 阿司匹林 氯吡格雷 冠心病心绞痛 血清高敏C-反应蛋白 肿瘤坏死因子-α 白细胞介素-6 Aspirin Clopidogrel Coronary heart disease angina Serum high-sensitivity C-reactive protein Tumor necrosis factor-alpha Interleukin-6
  • 相关文献

参考文献1

二级参考文献30

  • 1Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients pre- senting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267-315. 被引量:1
  • 2O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2013; 61: 485-510. 被引量:1
  • 3Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/ AHAJSCAI guideline for percutaneous coronary intervention: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guide- lines and the Society for Cardiovascular Angiography and Inter- ventions. Catheter Cardiovasc Interv 2013; 82: E266-E355. 被引量:1
  • 4Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: The task force on myocardial revascularization of the European Society of Car- diology (ESC) and the European Association for Cardio-Tho- racic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J2014; 35:2541-2619. 被引量:1
  • 5Angiolillo D J, Gibson CM, Cheng S, et al. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: Rando- mized, placebo-controlled, crossover comparison studies. Clin Pharmacol Ther 2011; 89: 65-74. 被引量:1
  • 6Frelinger AL 3rd, Lee RD, Mulford D J, et al. A randomized, 2-period, crossover design study to assess the effects of dex- lansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynarnics of clopidogrel in healthy volunteers. JAm Coil Cardio12012; 59: 1304-1311. 被引量:1
  • 7Shah BS, Parmar SA, Mahajan S, et al. An insight into the interaction between clopidogrel and proton pump inhibitors. CurrDrugMetab 2012; 13: 225-235. 被引量:1
  • 8Soft F, Giusti B, Marcucci R, et al. Cytochrome p450 2c19*2 polymorphism and cardiovascular recurrences in patients tak- ing clopidogrel: A meta-analysis. Pharmacogenomics J 2011; 11: 199-206. 被引量:1
  • 9Holmes MV, Perel P, Shah T, et al. Cyp2cl9 genotype, clo- pidogrel metabolism, platelet function, and cardiovascular events: A systematic review and meta-analysis. JAMA 2011; 306: 2704-2714. 被引量:1
  • 10Simon T, Steg PG, Gilard M, et al. Clinical events as a func- tion of proton pump inhibitor use, clopidogrel use, and cyto- chrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: Results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial In- farction (FAST-MI) registry. Circulation 2011; 123: 474-482. 被引量:1

共引文献11

同被引文献333

引证文献35

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部